UK: One in ten hospital trusts have been asked to approve unlicensed cannabis-based medicinal prescriptions

6d
2m read
Summary

Around 10% of hospital trusts have received requests for prescriptions of unlicensed cannabis-based medical products, according to a freedom of information request submitted by The Pharmaceutical Journal. The Pharmaceutical Journal writes… Exclusive: Around 10% of hospital trusts responding to a freedom of information request said they had received requests for prescriptions of unlicensed cannabis-based medical products since 1 November 2018. Nine of these trusts had approved requests, three had rejected them and one was pending a descision at the time of writing. Trusts were asked how many requests for prescriptions of unlicensed cannabis-based medical products (CBMPs) had been made though their trust’s drugs and therapeutics committee (or similar approval process) since cannabis was legalised for medical use on 1 November 2018. One trust had approved eight of these requests, with the others approving seven, six and five requests respectively.

Article Preview

The Pharmaceutical Journal writes…

Exclusive: Around 10% of hospital trusts responding to a freedom of information request said they had received requests for prescriptions of unlicensed cannabis-based medical products since 1 November 2018.

Around 10% of hospital trusts have received requests for prescriptions of unlicensed cannabis-based medical products, according to a freedom of information request submitted by The Pharmaceutical Journal.

Trusts were asked how many requests for prescriptions of unlicensed cannabis-based medical products (CBMPs) had been made though their trust’s drugs and therapeutics...

Read the full article @ Cannabis Law Report